Skip to main content

Andrew John Liu

Associate Professor of Neurology
Neurology, Behavioral Neurology
932 Morreene Rd, Room 258, Durham, NC 27705
932 Morreene Rd., Rm 258, Durham, NC 27705

Selected Presentations & Appearances


Biomarkers in Neurodegenerative Diseases · February 24, 2024 Invited Talk North Carolina Neurological Society,
Alzheimer's Disease dementia and biomarkers - Webinar · February 13, 2024 International Meeting or Conference Inside Precision Medicine,
Racial Disparities in Alzheimer's Disease research - Interdisciplinary Nutrition Sciences Symposium · September 14, 2023 Invited Talk UNC-Chapel Hill,
Discovering the neuropathological etiology of Tuberous Sclerosis Complex Associated Neuropsychiatric Disorders - 2023 International TSC Research Conference · September 7, 2023 Keynote/Named Lecture TSC Alliance, Washington D.C

This presentation explains how protein called phosphorylated tau, typically found in Alzheimer's Disease, could be the cause of Tuberous Sclerosis Complex Associated Neuropsychiatric Disorders (TAND) symptoms.

Implications of lecanemab after full FDA approval · July 7, 2023 Broadcast Appearance ABC 11 Eye witness news,
Biomarkers in Neurodegenerative Diseases · February 24, 2024 Invited Talk North Carolina Neurological Society,
Alzheimer's Disease dementia and biomarkers - Webinar · February 13, 2024 International Meeting or Conference Inside Precision Medicine,
Racial Disparities in Alzheimer's Disease research - Interdisciplinary Nutrition Sciences Symposium · September 14, 2023 Invited Talk UNC-Chapel Hill,
Discovering the neuropathological etiology of Tuberous Sclerosis Complex Associated Neuropsychiatric Disorders - 2023 International TSC Research Conference · September 7, 2023 Keynote/Named Lecture TSC Alliance, Washington D.C

This presentation explains how protein called phosphorylated tau, typically found in Alzheimer's Disease, could be the cause of Tuberous Sclerosis Complex Associated Neuropsychiatric Disorders (TAND) symptoms.

Implications of lecanemab after full FDA approval · July 7, 2023 Broadcast Appearance ABC 11 Eye witness news,
Implications on the pending full approval of lecanemab · July 6, 2023 Interview WPTF radio,
Implications on the pending full approval of lecanemab · July 6, 2023 Interview ABC 11 Eyewitness news,
MERIAD: Mechanisms in Epigenetics to explain Racial Inequalities in Alzheimer’s Disease - Grand Rounds · September 21, 2022 Lecture Duke University School of Medicine, Department of Neurology,
Onset of Tuberous Sclerosis Complex Associated Neuropsychiatric Disorder (TAND) - Webinar series · December 2, 2021 Invited Talk TSC Alliance , Virtual
Linking neurodevelopmental and neurodegenerative disorders - Grand Rounds · August 4, 2021 Lecture Duke University School of Medicine, Department of Neurology,
The clinical overlap between Behavioral and Vascular Neurology - Vascular Neurology lecture series · February 2021 - February 2021 Invited Talk Duke University School of Medicine, Department of Neurology, Division of Vascular Neurology, Duke University
Clinical Characterization of Neurodegenerative Disorders - Advance topics in neurology · January 2021 - January 2021 Invited Talk Duke University School of Medicine, Duke University
Investigating the racial disparities in Alzheimer’s Disease - TBS and Neurology Residency Poster Program · October 2020 Invited Talk Translational Brain Sciences,

Dr. Cathrine Hoyo and I believe epigenetic changes early in life may explain the racial disparities in the development of Alzheimer's disease dementia.

Linking Neurodevelopmental and Neurodegenerative disorders - Neurology Grand Rounds · September 2020 Invited Talk Brown University,
Disrupted Awareness - Neurobehavioral Conference · August 2020 Lecture Duke University, Department of Neurology, Duke University Hospital
Non-AD dementia: Diagnosis and Management - Duke Neurology and Neurosurgery Seminar · August 2020 Instructional Course, Workshop, or Symposium Duke University School of Medicine, Department of Neurology, Duke University Hospital (virtually through Zoom)
Advancements in Alzheimer's Disease - Geriatrics Grand Rounds · June 2020 Invited Talk Duke University's School of Medicine, Department of Geriatrics, Duke University Hospital (virtually through Zoom)
A Way with Words - Grand Rounds · February 2020 - February 2020 Lecture Duke University School of Medicine, Department of Neurology, Duke University Hospital (virtual through Zoom)

Present the clinical, neuropsychological and neuropathological characteristics of primary progressive aphasias (PPAs). The audience included geriatricians, psychiatrists and neurologists.

Neuropsychiatric symptoms in adults with Tuberous Sclerosis Complex · November 2, 2019 - November 3, 2019 Invited Talk Tuberous Sclerosis Alliance, UCLA campus

Present cognitive and behavioral symptoms in adults diagnosed with Tuberous Sclerosis Complex at the Tuberous Sclerosis Alliance regional conference.

Outreach & Engaged Scholarship


The relationship between memory and olfaction. · April 2023 Community Outreach Stuyvesant High School , New York City
It’s a long, grieving process:’ Alzheimer’s devastating impact and the search for a cure · March 29, 2023 Community Outreach Los Angeles Times
Maintaining brain health in older adults · May 18, 2022 Community Outreach Rex Arthritis Fibromylagia and Chronic Pain support group
Mentoring and informing - Caregiver Support in the African American Community · November 16, 2021 Community Outreach Duke Dementia Caregiver Support group , virtual

Service to the Profession


NIH study section reviewer · March 2024 Committee Service
Committee member - National Alzheimer's Coordinating Center (NACC) Biomarker workgroup · January 2024 Committee Service NIA Alzheimer's Disease Research Center,
Committee member - Working group for adults with Tuberous Sclerosis Complex Associated Neuropsychiatric Disorders (TAND). · November 2023 Committee Service TSC Alliance,
Early Career Reviewer · May 28, 2022 Editorial Activities NIH,
Associate clinical core lead and executive committee member - Alzheimer's Disease Research Center · October 2020 Committee Service Duke University School of Medicine,

Academic & Administrative Activities


Duke University School of Medicine, Department of Neurology, Behavioral Neurology Training Program Director.

Duke University School of medicine, Department of Neurology, Director of Biomarker Discovery

Alzheimer's Drug Discovery Foundation Scientific Review Board member.

Reviewer for the journal "Alzheimer's & Dementia: The Journal of the Alzheimer's Association."
 
Reviewer for the journal "Neurocase."

Clinical Activities


-Behavioral neurology clinic at Duke University's Morreene Rd
-Lumbar puncture clinic at Duke University's Morreene Rd.
-Consult attending at the Duke University Hospital
-Evaluate patients for CSF dysfunction at Duke University's Morreene Rd Clinic.